Top compounds associated with response to SPRY4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:decitabine (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	9e-06
mRNA	CHIR-99021	GDSC1000	pan-cancer	AAC	0.15	1e-05
mRNA	CI-1040	GDSC1000	pan-cancer	AAC	0.16	1e-05
mRNA	selumetinib:tretinoin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	1e-05
mRNA	selumetinib:vorinostat (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	1e-05
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	3e-05
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	3e-05
mRNA	RO4929097	CTRPv2	pan-cancer	AAC	0.22	6e-05
mRNA	Nutlin-3a (-)	GDSC1000	pan-cancer	AAC	0.15	6e-05
mRNA	17-AAG	GDSC1000	pan-cancer	AAC	0.14	8e-05

Download CSV